Skip to main content

Jobs at Dr.Reddy's Laboratories Pvt.Ltd

Dr. Reddy's -walk-in Drive for Quality Assurance in Visakhapatnam
Company: Dr. Reddys Laboratories Ltd.
Experience: 3 to 8 yrs
Location: Visakhapatnam/Vizag
Walk-in details: Date- 24th April, Starting Time: 9 AM

Job Description

Dr. Reddy's Laboratories Ltd. - Walk-in Drive for Quality Assurance - Injectables and OSD Plants based at Visakhapatnam

Candidates matching below criteria can Walk-in directly with their updated resume and latest increment letter.

Venue:
The Ramachandra Ridge Hotel,
NH-5 Road Opp:All India Radio Station,
Kurmanapalem, Visakhapatnam,
Andhra Pradesh 530046

Contact person: Aparna Pandit, Human Resources

Experience: 3 - 8 years

Qualification: M. Pharm / B. Pharm / M. Sc with experience in IPQA, IPQA - Packing, QMS, Analytical Assurance, Documentation, CSV, Validations, Compliance, Engineering Assurance

Note: M. Pharm candidates with QC reviewer experience can apply for Analytical Assurance

Computer system validation
Experience: 4 - 8 years
Qualification: M. Pharm / B. Pharm / M. Sc, BCA, MCA, B. Tech with experience in Computer system validation (CSV), QMS, Compliance

Engineering Assurance.
Experience: 4 - 8 years
Qualification: M. Pharm/B. Pharm /M. Sc/B. Tech with experience in Validation, Qualification in process area

Note 1: Aggregate of 60 % marks in their highest qualification is mandatory for all the above positions.

Note 2: minimum two years stability in atleast last two companies in mandatory

Please refer your friends as we have multiple openings
Role: Quality Assurance/Quality Control Executive
Role Category: Production/Manufacturing/Maintenance
Industry Type: Pharma / Biotech / Clinical Research
Functional Area: Production, Manufacturing, Maintenance
Keywords: Quality assurance, QA, IPQA, QMS, Documentation, CSV, Engineering assurance, validation

Desired Candidate Profile

Education: (UG - B.Sc - Any Specialization, Any Specialization, B.Pharma - Pharmacy, Pharmacy, B.Tech/B.E. - Any Specialization, BCA - Computers) OR (PG - Any Post Graduate - Any Specialization) AND (Doctorate - Any Doctorate - Any Specialization, Doctorate Not Required)

Company Profile
Dr. Reddys Laboratories Ltd.
http://www.drreddys.com
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets. For more information, log on to: www.drreddys.com

Comments

Post a Comment

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...
1 comment
Read more

Novo Nordisk settles with 2 Florida venders of compounded (Semaglutide)Ozempic:

Novo Nordisk settles with 2 Florida venders of compounded Ozempic: Novo Nordisk has arrived at private settlements with two Florida merchants of intensified forms of the uber blockbuster semaglutide therapies Ozempic and Wegovy, the organization said on Friday. In June of last year, Novo recorded brand name encroachment claims against five dealers of knockoff renditions of the GLP-1 medications, which have seen soaring interest to battle weight reduction. Ekzotica Corp's. Restorative Laser Experts Drug Spa in Miami and Effinger Wellbeing's Nuvida Rx Weight reduction in Tallahassee are the initial two organizations to have settled their cases. As indicated by long-lasting directive orders, the dealers will quit utilizing Novo reserve and have consented to reveal for a considerable length of time that intensified variants of the medications have not gone through the security and viability norms expected by the FDA for supported drugs. "The litigants' unlawful showcasing ...
Post a Comment
Read more

Hypertension-An Overview

INTRODUCTION: Systemic arterial hypertension is one of the strongest known modifiable risk factors for ischaemic heart disease, stroke, renal failure and heart failure. It remains poorly treated. As an asymptomatic disorder, people are understandably reluctant to accept adverse drug effects in addition to the inconvenience of long-term treatment. In this regard, modern drugs represent an enormous improvement. PATHOPHYSIOLOGY AND SITES OF DRUG ACTION Hypertension is occasionally secondary to some distinct disease. However, most patients with persistent arterial hypertension have essential hypertension. Arterial blood pressure is determined by cardiac output, peripheral vascular resistance and large artery compliance. Peripheral vascular resistance is determined by the diameter of resistance vessels (small muscular arteries and arterioles) in the various tissues. One or more of a ‘mosaic’ of interconnected predisposing factors (including positive family history, obesity and phys...
Post a Comment
Read more